nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—Renal impairment—Doxorubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Perindopril—Face oedema—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Perindopril—Purpura—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Perindopril—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Perindopril—Asthenia—Sorafenib—thyroid cancer	0.00141	0.00141	CcSEcCtD
Perindopril—Cardiac arrest—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Perindopril—Mood swings—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Perindopril—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Perindopril—Pruritus—Sorafenib—thyroid cancer	0.0014	0.0014	CcSEcCtD
Perindopril—Blood creatinine increased—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Perindopril—Hyponatraemia—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Perindopril—Pain in extremity—Doxorubicin—thyroid cancer	0.00137	0.00137	CcSEcCtD
Perindopril—Dry skin—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Perindopril—Abdominal pain upper—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Perindopril—Orthostatic hypotension—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Perindopril—Migraine—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Perindopril—Diarrhoea—Sorafenib—thyroid cancer	0.00135	0.00135	CcSEcCtD
Perindopril—Breast disorder—Epirubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Perindopril—Nasopharyngitis—Epirubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Perindopril—Face oedema—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Perindopril—Muscular weakness—Epirubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Perindopril—Cardiac arrest—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Perindopril—Dizziness—Sorafenib—thyroid cancer	0.0013	0.0013	CcSEcCtD
Perindopril—Mood swings—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Perindopril—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Perindopril—Asthma—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Perindopril—Eosinophilia—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Perindopril—Dry skin—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Perindopril—Pancreatitis—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Perindopril—Vomiting—Sorafenib—thyroid cancer	0.00125	0.00125	CcSEcCtD
Perindopril—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Perindopril—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Perindopril—Angina pectoris—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Perindopril—Rash—Sorafenib—thyroid cancer	0.00124	0.00124	CcSEcCtD
Perindopril—Dermatitis—Sorafenib—thyroid cancer	0.00124	0.00124	CcSEcCtD
Perindopril—Breast disorder—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Perindopril—Headache—Sorafenib—thyroid cancer	0.00124	0.00124	CcSEcCtD
Perindopril—Bronchitis—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Perindopril—Nasopharyngitis—Doxorubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Perindopril—Pancytopenia—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Perindopril—Muscular weakness—Doxorubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Perindopril—Neutropenia—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Perindopril—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Perindopril—Asthma—Doxorubicin—thyroid cancer	0.00119	0.00119	CcSEcCtD
Perindopril—Pollakiuria—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Perindopril—Eosinophilia—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Perindopril—Nausea—Sorafenib—thyroid cancer	0.00117	0.00117	CcSEcCtD
Perindopril—Photosensitivity reaction—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Perindopril—Pancreatitis—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Perindopril—Angina pectoris—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Perindopril—Pneumonia—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Perindopril—Drowsiness—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Perindopril—Bronchitis—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Perindopril—Pancytopenia—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Perindopril—Renal failure—Epirubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Perindopril—Jaundice—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Perindopril—Stomatitis—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Perindopril—Urinary tract infection—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Perindopril—Conjunctivitis—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Perindopril—Neutropenia—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Perindopril—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Perindopril—Sweating—Epirubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Perindopril—Pollakiuria—Doxorubicin—thyroid cancer	0.0011	0.0011	CcSEcCtD
Perindopril—Haematuria—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Perindopril—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Perindopril—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Perindopril—Epistaxis—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Perindopril—Sinusitis—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Perindopril—Agranulocytosis—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Perindopril—Pneumonia—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Perindopril—Drowsiness—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.00105	0.00105	CcSEcCtD
Perindopril—Bradycardia—Epirubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Perindopril—Renal failure—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Perindopril—Haemoglobin—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perindopril—Jaundice—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perindopril—Stomatitis—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perindopril—Rhinitis—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perindopril—Urinary tract infection—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perindopril—Conjunctivitis—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perindopril—Haemorrhage—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perindopril—Hepatitis—Epirubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Perindopril—Pharyngitis—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Perindopril—Sweating—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Perindopril—Urinary tract disorder—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Perindopril—Oedema peripheral—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Perindopril—Haematuria—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Perindopril—Urethral disorder—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Perindopril—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Perindopril—Epistaxis—Doxorubicin—thyroid cancer	0.000997	0.000997	CcSEcCtD
Perindopril—Sinusitis—Doxorubicin—thyroid cancer	0.000992	0.000992	CcSEcCtD
Perindopril—Visual impairment—Epirubicin—thyroid cancer	0.000989	0.000989	CcSEcCtD
Perindopril—Agranulocytosis—Doxorubicin—thyroid cancer	0.000987	0.000987	CcSEcCtD
Perindopril—Erythema multiforme—Epirubicin—thyroid cancer	0.00097	0.00097	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—thyroid cancer	0.000966	0.000966	CcSEcCtD
Perindopril—Eye disorder—Epirubicin—thyroid cancer	0.000959	0.000959	CcSEcCtD
Perindopril—Tinnitus—Epirubicin—thyroid cancer	0.000956	0.000956	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—thyroid cancer	0.000954	0.000954	CcSEcCtD
Perindopril—Flushing—Epirubicin—thyroid cancer	0.000952	0.000952	CcSEcCtD
Perindopril—Cardiac disorder—Epirubicin—thyroid cancer	0.000952	0.000952	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—thyroid cancer	0.000952	0.000952	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—thyroid cancer	0.000949	0.000949	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—thyroid cancer	0.000949	0.000949	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—thyroid cancer	0.000942	0.000942	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000937	0.000937	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—thyroid cancer	0.000935	0.000935	CcSEcCtD
Perindopril—Angiopathy—Epirubicin—thyroid cancer	0.000931	0.000931	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—thyroid cancer	0.00093	0.00093	CcSEcCtD
Perindopril—Mediastinal disorder—Epirubicin—thyroid cancer	0.000925	0.000925	CcSEcCtD
Perindopril—Chills—Epirubicin—thyroid cancer	0.00092	0.00092	CcSEcCtD
Perindopril—Arrhythmia—Epirubicin—thyroid cancer	0.000916	0.000916	CcSEcCtD
Perindopril—Visual impairment—Doxorubicin—thyroid cancer	0.000915	0.000915	CcSEcCtD
Perindopril—Alopecia—Epirubicin—thyroid cancer	0.000907	0.000907	CcSEcCtD
Perindopril—Mental disorder—Epirubicin—thyroid cancer	0.000899	0.000899	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—thyroid cancer	0.000897	0.000897	CcSEcCtD
Perindopril—Malnutrition—Epirubicin—thyroid cancer	0.000893	0.000893	CcSEcCtD
Perindopril—Erythema—Epirubicin—thyroid cancer	0.000893	0.000893	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—thyroid cancer	0.000887	0.000887	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—thyroid cancer	0.000885	0.000885	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—thyroid cancer	0.000881	0.000881	CcSEcCtD
Perindopril—Flushing—Doxorubicin—thyroid cancer	0.000881	0.000881	CcSEcCtD
Perindopril—Flatulence—Epirubicin—thyroid cancer	0.00088	0.00088	CcSEcCtD
Perindopril—Tension—Epirubicin—thyroid cancer	0.000876	0.000876	CcSEcCtD
Perindopril—Dysgeusia—Epirubicin—thyroid cancer	0.000875	0.000875	CcSEcCtD
Perindopril—Nervousness—Epirubicin—thyroid cancer	0.000867	0.000867	CcSEcCtD
Perindopril—Back pain—Epirubicin—thyroid cancer	0.000864	0.000864	CcSEcCtD
Perindopril—Angiopathy—Doxorubicin—thyroid cancer	0.000861	0.000861	CcSEcCtD
Perindopril—Muscle spasms—Epirubicin—thyroid cancer	0.000859	0.000859	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000855	0.000855	CcSEcCtD
Perindopril—Chills—Doxorubicin—thyroid cancer	0.000852	0.000852	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—thyroid cancer	0.000848	0.000848	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—thyroid cancer	0.000839	0.000839	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—thyroid cancer	0.000832	0.000832	CcSEcCtD
Perindopril—Ill-defined disorder—Epirubicin—thyroid cancer	0.000829	0.000829	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—thyroid cancer	0.000826	0.000826	CcSEcCtD
Perindopril—Erythema—Doxorubicin—thyroid cancer	0.000826	0.000826	CcSEcCtD
Perindopril—Anaemia—Epirubicin—thyroid cancer	0.000825	0.000825	CcSEcCtD
Perindopril—Agitation—Epirubicin—thyroid cancer	0.000821	0.000821	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—thyroid cancer	0.000814	0.000814	CcSEcCtD
Perindopril—Tension—Doxorubicin—thyroid cancer	0.000811	0.000811	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—thyroid cancer	0.000809	0.000809	CcSEcCtD
Perindopril—Malaise—Epirubicin—thyroid cancer	0.000805	0.000805	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—thyroid cancer	0.000803	0.000803	CcSEcCtD
Perindopril—Vertigo—Epirubicin—thyroid cancer	0.000802	0.000802	CcSEcCtD
Perindopril—Syncope—Epirubicin—thyroid cancer	0.000801	0.000801	CcSEcCtD
Perindopril—Leukopenia—Epirubicin—thyroid cancer	0.000799	0.000799	CcSEcCtD
Perindopril—Back pain—Doxorubicin—thyroid cancer	0.000799	0.000799	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—thyroid cancer	0.000794	0.000794	CcSEcCtD
Perindopril—Palpitations—Epirubicin—thyroid cancer	0.000789	0.000789	CcSEcCtD
Perindopril—Loss of consciousness—Epirubicin—thyroid cancer	0.000785	0.000785	CcSEcCtD
Perindopril—Cough—Epirubicin—thyroid cancer	0.000779	0.000779	CcSEcCtD
Perindopril—Hypertension—Epirubicin—thyroid cancer	0.000771	0.000771	CcSEcCtD
Perindopril—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000767	0.000767	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—thyroid cancer	0.000764	0.000764	CcSEcCtD
Perindopril—Arthralgia—Epirubicin—thyroid cancer	0.00076	0.00076	CcSEcCtD
Perindopril—Chest pain—Epirubicin—thyroid cancer	0.00076	0.00076	CcSEcCtD
Perindopril—Myalgia—Epirubicin—thyroid cancer	0.00076	0.00076	CcSEcCtD
Perindopril—Agitation—Doxorubicin—thyroid cancer	0.000759	0.000759	CcSEcCtD
Perindopril—Anxiety—Epirubicin—thyroid cancer	0.000758	0.000758	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000755	0.000755	CcSEcCtD
Perindopril—Discomfort—Epirubicin—thyroid cancer	0.000751	0.000751	CcSEcCtD
Perindopril—Malaise—Doxorubicin—thyroid cancer	0.000745	0.000745	CcSEcCtD
Perindopril—Dry mouth—Epirubicin—thyroid cancer	0.000744	0.000744	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—thyroid cancer	0.000742	0.000742	CcSEcCtD
Perindopril—Syncope—Doxorubicin—thyroid cancer	0.000741	0.000741	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—thyroid cancer	0.00074	0.00074	CcSEcCtD
Perindopril—Confusional state—Epirubicin—thyroid cancer	0.000735	0.000735	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—thyroid cancer	0.00073	0.00073	CcSEcCtD
Perindopril—Anaphylactic shock—Epirubicin—thyroid cancer	0.000729	0.000729	CcSEcCtD
Perindopril—Oedema—Epirubicin—thyroid cancer	0.000729	0.000729	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—thyroid cancer	0.000726	0.000726	CcSEcCtD
Perindopril—Cough—Doxorubicin—thyroid cancer	0.000721	0.000721	CcSEcCtD
Perindopril—Shock—Epirubicin—thyroid cancer	0.000717	0.000717	CcSEcCtD
Perindopril—Nervous system disorder—Epirubicin—thyroid cancer	0.000715	0.000715	CcSEcCtD
Perindopril—Thrombocytopenia—Epirubicin—thyroid cancer	0.000714	0.000714	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—thyroid cancer	0.000713	0.000713	CcSEcCtD
Perindopril—Tachycardia—Epirubicin—thyroid cancer	0.000711	0.000711	CcSEcCtD
Perindopril—Skin disorder—Epirubicin—thyroid cancer	0.000708	0.000708	CcSEcCtD
Perindopril—Hyperhidrosis—Epirubicin—thyroid cancer	0.000705	0.000705	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—thyroid cancer	0.000703	0.000703	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—thyroid cancer	0.000703	0.000703	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—thyroid cancer	0.000703	0.000703	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—thyroid cancer	0.000701	0.000701	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000699	0.000699	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—thyroid cancer	0.000695	0.000695	CcSEcCtD
Perindopril—Anorexia—Epirubicin—thyroid cancer	0.000695	0.000695	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—thyroid cancer	0.000688	0.000688	CcSEcCtD
Perindopril—Hypotension—Epirubicin—thyroid cancer	0.000681	0.000681	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—thyroid cancer	0.00068	0.00068	CcSEcCtD
Perindopril—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000674	0.000674	CcSEcCtD
Perindopril—Oedema—Doxorubicin—thyroid cancer	0.000674	0.000674	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000664	0.000664	CcSEcCtD
Perindopril—Shock—Doxorubicin—thyroid cancer	0.000663	0.000663	CcSEcCtD
Perindopril—Nervous system disorder—Doxorubicin—thyroid cancer	0.000661	0.000661	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—thyroid cancer	0.00066	0.00066	CcSEcCtD
Perindopril—Insomnia—Epirubicin—thyroid cancer	0.000659	0.000659	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—thyroid cancer	0.000658	0.000658	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—thyroid cancer	0.000655	0.000655	CcSEcCtD
Perindopril—Paraesthesia—Epirubicin—thyroid cancer	0.000654	0.000654	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000652	0.000652	CcSEcCtD
Perindopril—Dyspnoea—Epirubicin—thyroid cancer	0.00065	0.00065	CcSEcCtD
Perindopril—Somnolence—Epirubicin—thyroid cancer	0.000648	0.000648	CcSEcCtD
Perindopril—Anorexia—Doxorubicin—thyroid cancer	0.000643	0.000643	CcSEcCtD
Perindopril—Dyspepsia—Epirubicin—thyroid cancer	0.000642	0.000642	CcSEcCtD
Perindopril—Decreased appetite—Epirubicin—thyroid cancer	0.000634	0.000634	CcSEcCtD
Perindopril—Hypotension—Doxorubicin—thyroid cancer	0.00063	0.00063	CcSEcCtD
Perindopril—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000629	0.000629	CcSEcCtD
Perindopril—Fatigue—Epirubicin—thyroid cancer	0.000628	0.000628	CcSEcCtD
Perindopril—Pain—Epirubicin—thyroid cancer	0.000623	0.000623	CcSEcCtD
Perindopril—Constipation—Epirubicin—thyroid cancer	0.000623	0.000623	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000614	0.000614	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—thyroid cancer	0.00061	0.00061	CcSEcCtD
Perindopril—Paraesthesia—Doxorubicin—thyroid cancer	0.000606	0.000606	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—thyroid cancer	0.000601	0.000601	CcSEcCtD
Perindopril—Feeling abnormal—Epirubicin—thyroid cancer	0.000601	0.000601	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—thyroid cancer	0.0006	0.0006	CcSEcCtD
Perindopril—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000596	0.000596	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—thyroid cancer	0.000594	0.000594	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—thyroid cancer	0.000586	0.000586	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000582	0.000582	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—thyroid cancer	0.000581	0.000581	CcSEcCtD
Perindopril—Urticaria—Epirubicin—thyroid cancer	0.000579	0.000579	CcSEcCtD
Perindopril—Pain—Doxorubicin—thyroid cancer	0.000577	0.000577	CcSEcCtD
Perindopril—Constipation—Doxorubicin—thyroid cancer	0.000577	0.000577	CcSEcCtD
Perindopril—Abdominal pain—Epirubicin—thyroid cancer	0.000576	0.000576	CcSEcCtD
Perindopril—Body temperature increased—Epirubicin—thyroid cancer	0.000576	0.000576	CcSEcCtD
Perindopril—Feeling abnormal—Doxorubicin—thyroid cancer	0.000556	0.000556	CcSEcCtD
Perindopril—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000551	0.000551	CcSEcCtD
Perindopril—Urticaria—Doxorubicin—thyroid cancer	0.000536	0.000536	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—thyroid cancer	0.000533	0.000533	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—thyroid cancer	0.000533	0.000533	CcSEcCtD
Perindopril—Asthenia—Epirubicin—thyroid cancer	0.000523	0.000523	CcSEcCtD
Perindopril—Pruritus—Epirubicin—thyroid cancer	0.000516	0.000516	CcSEcCtD
Perindopril—Diarrhoea—Epirubicin—thyroid cancer	0.000499	0.000499	CcSEcCtD
Perindopril—Asthenia—Doxorubicin—thyroid cancer	0.000484	0.000484	CcSEcCtD
Perindopril—Dizziness—Epirubicin—thyroid cancer	0.000482	0.000482	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—thyroid cancer	0.000477	0.000477	CcSEcCtD
Perindopril—Vomiting—Epirubicin—thyroid cancer	0.000463	0.000463	CcSEcCtD
Perindopril—Diarrhoea—Doxorubicin—thyroid cancer	0.000461	0.000461	CcSEcCtD
Perindopril—Rash—Epirubicin—thyroid cancer	0.00046	0.00046	CcSEcCtD
Perindopril—Dermatitis—Epirubicin—thyroid cancer	0.000459	0.000459	CcSEcCtD
Perindopril—Headache—Epirubicin—thyroid cancer	0.000457	0.000457	CcSEcCtD
Perindopril—Dizziness—Doxorubicin—thyroid cancer	0.000446	0.000446	CcSEcCtD
Perindopril—Nausea—Epirubicin—thyroid cancer	0.000433	0.000433	CcSEcCtD
Perindopril—Vomiting—Doxorubicin—thyroid cancer	0.000429	0.000429	CcSEcCtD
Perindopril—Rash—Doxorubicin—thyroid cancer	0.000425	0.000425	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—thyroid cancer	0.000425	0.000425	CcSEcCtD
Perindopril—Headache—Doxorubicin—thyroid cancer	0.000422	0.000422	CcSEcCtD
Perindopril—Nausea—Doxorubicin—thyroid cancer	0.000401	0.000401	CcSEcCtD
